These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25668278)

  • 41. Risks of testosterone replacement.
    Shames DA
    N Engl J Med; 2004 May; 350(19):2004-6; author reply 2004-6. PubMed ID: 15128905
    [No Abstract]   [Full Text] [Related]  

  • 42. Testosterone may speed up the growth of prostate cancer due to aromatase activity.
    Friedman AE
    BJU Int; 2010 Aug; 106(3):434. PubMed ID: 20653657
    [No Abstract]   [Full Text] [Related]  

  • 43. Prostate cancer risk in testosterone-treated men.
    Raynaud JP
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer.
    Morgentaler A; Traish AM
    Investig Clin Urol; 2020 Jul; 61(4):452-454. PubMed ID: 32666003
    [No Abstract]   [Full Text] [Related]  

  • 45. Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy.
    McGill JJ; Shoskes DA; Sabanegh ES
    Cleve Clin J Med; 2012 Nov; 79(11):797-806. PubMed ID: 23125330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on prostatic cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate by Charles Huggins and Clarence V. Hodges.
    Glina S; Rivero MA; Morales A; Morgentaler A
    J Sex Med; 2010 Feb; 7(2 Pt 1):640-4. PubMed ID: 20492413
    [No Abstract]   [Full Text] [Related]  

  • 47. Metastatic prostate cancer after orchiectomy, radiotherapy, and testosterone replacement in a patient with bilateral seminoma.
    Manassero F; Erba P; Mariani G; Mogorovich A; Giannarini G; Selli C
    J Androl; 2007; 28(1):10-2. PubMed ID: 16899814
    [No Abstract]   [Full Text] [Related]  

  • 48. The mechanism of action of estrogen in castration-resistant prostate cancer: clues from hormone levels.
    Aggarwal R; Weinberg V; Small EJ; Oh W; Rushakoff R; Ryan CJ
    Clin Genitourin Cancer; 2009 Oct; 7(3):E71-6. PubMed ID: 19815485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hormonotherapy of so-called solid tumors].
    Cappelaere P
    Sem Hop; 1972 Jan; 48(4):279-82. PubMed ID: 4338349
    [No Abstract]   [Full Text] [Related]  

  • 50. Feeling deflated? The low-T industry wants to pump you up. The promise. The science. The risk.
    Von Drehle D
    Time; 2014 Aug; 184(6):36-43. PubMed ID: 25219087
    [No Abstract]   [Full Text] [Related]  

  • 51. Assessment and management of male androgen disorders: an update.
    Chan I; Fui MN; Zajac JD; Grossmann M
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prostatic cancer and its prognosis under Honvan treatment].
    Gaca A; Köhnlein HE; Köttgen H
    Med Welt; 1968 Apr; 15():961-7. PubMed ID: 5717752
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hormone therapy in prostate cancer: clinical results].
    Morote-Robles J
    Rev Esp Fisiol; 1990 Mar; 46(1):59-62. PubMed ID: 1697693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men.
    Rosen RC; Wu FC; Behre HM; Roehrborn CG; Schröder FH; Siami FS; Martha JF; Finn JD; Araujo AB
    Aging Male; 2013 Mar; 16(1):1-7. PubMed ID: 23373674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy.
    Klap J; Schmid M; Loughlin KR
    J Urol; 2015 Feb; 193(2):403-13. PubMed ID: 25260832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pill and the pendulum.
    Schiff I
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):228-9. PubMed ID: 17666594
    [No Abstract]   [Full Text] [Related]  

  • 57. Prostate cancer drugs could pose risk to heart health. FDA reviewing safety of anti-hormone treatments due to links with heart disease and diabetes.
    Heart Advis; 2010 Aug; 13(8):5. PubMed ID: 22792575
    [No Abstract]   [Full Text] [Related]  

  • 58. Should testosterone replacement be given to men with large prostates?
    Marks LS; Kaplan SA
    J Urol; 2009 Nov; 182(5):2109-11. PubMed ID: 19758636
    [No Abstract]   [Full Text] [Related]  

  • 59. Testosterone therapy in women with androgen deficiency: Its time has come.
    Guay A; Traish A
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1116-26. PubMed ID: 20872314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re: Prostate cancer in men using testosterone supplementation. F. D. Gaylis, D. W. Lin, J. M. Ignatoff, C. L. Amling, R. F. Tutrone and D. J. Cosgrove.
    Morgentaler A; Rhoden EL; Barqawi AB; Crawford ED
    J Urol; 2006 Apr; 175(4):1572; author reply 1573-4. PubMed ID: 16516047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.